Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price

AMPHStock
$25.87+11.41%52W
Market Cap$1.10B
P/E11.22x
PEG Ratio0.10
Div yield—
Beta0.96

AMPH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)11.10%
Price vs S&P 500 (4W)7.00%
PEG Ratio0.10
VGM Score71.65
P/E Ratio (Annual)11.22x

AMPH Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$0.61$0.91+48.26%(+$0.30)
Q1 2026$0.71$0.42-40.46%(-$0.29)
Q4 2025$0.92$0.73-20.50%(-$0.19)
Q3 2025$0.83$0.93+12.68%(+$0.10)
Q2 2025$0.74$0.85+14.62%(+$0.11)

AMPH Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.58
2.50
2.50
2.50

Industry Peers — Pharmaceuticals(574)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)EPS Growth (5Y)Price
AMPHAmphastar Pharmaceuticals, Inc.
BBB1.5x1.0%47.7%134.8%$25.87
LLYEli Lilly & Co.DBA14.9x49.6%83.4%27.6%$1257.03
JNJJohnson & JohnsonDCB6.2x7.8%67.7%14.9%$255.56
ABBVABBVIE INC.DCA7.8x10.4%72.8%-2.9%$285.42
MRKMerck & Co., Inc.DCA5.4x4.6%77.3%21.2%$145.95
NVSNovartis AGCCB4.9x3.3%75.0%15.3%$150.62
AZNAstraZeneca PLCCBB4.3x8.6%81.3%21.9%$165.41
ABTAbbott LaboratoriesCCB3.9x8.1%56.8%8.2%$104.89
NVONovo-Nordisk A/SBCC3.5x5.6%80.7%20.7%$38.83
PFEPfizer Inc.CDA2.6x-0.2%74.7%-3.5%$29.58
VRTXVertex Pharmaceuticals IncDCB10.1x10.2%86.0%8.3%$499.74

About Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals manufactures generic and proprietary injectable, inhalation, intranasal, and insulin products for hospitals and urgent care settings. Its products are distributed through group purchasing organizations and drug wholesalers, with operations primarily in the United States and supplemented by facilities in China and France.